P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000848572.60330.2f |
| _version_ | 1797287978931847168 |
|---|---|
| author | J. Xavier-Ferrucio C. Luo G. Angelini S. Krishnamurthy N. Patel M. Pettiglio T. Collingsworth M. Isik A. Ghodssi A. Halfond J. Etchin Y. Keschner G. Mundelboim P. Tavares C. Cummins A. Falla D. Hazelbaker E. Paik J. Sanchez G. Ge J. Lydeard M. I. Lin T. Chakraborty |
| author_facet | J. Xavier-Ferrucio C. Luo G. Angelini S. Krishnamurthy N. Patel M. Pettiglio T. Collingsworth M. Isik A. Ghodssi A. Halfond J. Etchin Y. Keschner G. Mundelboim P. Tavares C. Cummins A. Falla D. Hazelbaker E. Paik J. Sanchez G. Ge J. Lydeard M. I. Lin T. Chakraborty |
| author_sort | J. Xavier-Ferrucio |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:42:39Z |
| format | Article |
| id | doaj.art-8fc7f8fdd4574f619cc085f1e581daee |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:42:39Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-8fc7f8fdd4574f619cc085f1e581daee2024-03-02T03:29:17ZengWileyHemaSphere2572-92412022-06-0161312131310.1097/01.HS9.0000848572.60330.2f202206003-01312P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.J. Xavier-Ferrucio0C. Luo1G. Angelini2S. Krishnamurthy3N. Patel4M. Pettiglio5T. Collingsworth6M. Isik7A. Ghodssi8A. Halfond9J. Etchin10Y. Keschner11G. Mundelboim12P. Tavares13C. Cummins14A. Falla15D. Hazelbaker16E. Paik17J. Sanchez18G. Ge19J. Lydeard20M. I. Lin21T. Chakraborty221 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of America1 Vor Biopharma, Cambridge, United States of Americahttp://journals.lww.com/10.1097/01.HS9.0000848572.60330.2f |
| spellingShingle | J. Xavier-Ferrucio C. Luo G. Angelini S. Krishnamurthy N. Patel M. Pettiglio T. Collingsworth M. Isik A. Ghodssi A. Halfond J. Etchin Y. Keschner G. Mundelboim P. Tavares C. Cummins A. Falla D. Hazelbaker E. Paik J. Sanchez G. Ge J. Lydeard M. I. Lin T. Chakraborty P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT. HemaSphere |
| title | P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT. |
| title_full | P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT. |
| title_fullStr | P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT. |
| title_full_unstemmed | P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT. |
| title_short | P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT. |
| title_sort | p1429 multiplex deletion of myeloid antigens cd33 and cll 1 by crispr cas9 in human hematopoietic stem cells highlights the potential of next generation transplants for aml treatment |
| url | http://journals.lww.com/10.1097/01.HS9.0000848572.60330.2f |
| work_keys_str_mv | AT jxavierferrucio p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT cluo p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT gangelini p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT skrishnamurthy p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT npatel p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT mpettiglio p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT tcollingsworth p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT misik p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT aghodssi p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT ahalfond p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT jetchin p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT ykeschner p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT gmundelboim p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT ptavares p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT ccummins p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT afalla p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT dhazelbaker p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT epaik p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT jsanchez p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT gge p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT jlydeard p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT milin p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment AT tchakraborty p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment |